Sponsor study identifier
interventional
44
1 country
1
Study Start
December 18, 2020
Actual (reported)Primary Completion
September 27, 2024
Actual (reported)Study Completion
September 27, 2024
Actual (reported)The DULCINEA study aims to develop and validate a new therapy that integrates essential language characteristics and functional communication by dubbing scenes from television series that represent daily situations. It will be a randomized, crossed over, interventional pilot study recruiting 54 patients with poststroke nonfluent aphasia. Patients will be treated individually in 40-minute sessions twice a week for 8 weeks. In each session, a speech therapist and an actor will select the clips with muted words or sentences that have been detected as functionally meaningful for each patient. Outcomes will be assessed as significant differences in two aphasia tests.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
September 27, 2024
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
February 20, 2020
Actual (reported)February 28, 2020
Actual (reported)December 18, 2020
Actual (reported)September 27, 2024
Actual (reported)September 27, 2024
Actual (reported)Communicative Activity Log (CAL) questionnaire
Questionnaire that evaluates quantity and quality of aphasic patient communication, with 18 different questions in each item. Each question belonging to these two items is answered as a 6 point scale, where 0 is the worst and 5 is the best score.
Changes in score at six months
Boston Diagnostic Aphasia Examination (BDAE)
Neuropsycological battery that evaluates language skills based on perceptual modalities (auditory, visual, and gestural), processing functions (comprehension, analysis, problem-solving), and response modalities (writing, articulation, and manipulation). There are five subtests which include: conversational and expository speech, auditory comprehension, oral expression, reading, and writing. Its results can be used to classify patient's language profiles into one of the localization based classifications of aphasia, and it also provides a severity rating.
Changes in score at six months
General Health Questionnaire (GQH-12)
Changes in score at six months
Stroke and aphasia Quality of Life Scale (SAQOL-39)
Changes in score at six months
Western Aphasia Battery Revised (WAB-R)
Changes in score at six months
Stroke Aphasic Depression Questionnaire (SADQ10)
Changes in score at six months
27 patients that will receive study specific speech therapy in the first 3 months since study inclusion. From months 3-6 they will be group 2 controls.
27 patients that will receive study specific speech therapy during months 3-6 since study inclusion. During the first 3 months of the study period, they will be group 1 controls.
17 therapy sessions in which the patients will be asked to dubb words or sentences from television series previously considered functionally meaningful for them.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
La Paz University Hospital
Madrid, 28046, Spain
Fuentes B, de la Fuente-Gomez L, Sempere-Iborra C, Delgado-Fernandez C, Tarifa-Rodriguez A, Alonso de Lecinana M, de Celis-Ruiz E, Gutierrez-Zuniga R, Lopez-Tappero J, Martin Alonso M, Pastor-Yborra S, Rigual R, Ruiz-Ares G, Rodriguez-Pardo J, Virues-Ortega J, Borobia AM, Blanco P, Bueno-Guerra N. DUbbing Language-therapy CINEma-based in Aphasia post-Stroke (DULCINEA): study protocol for a randomized crossover pilot trial. Trials. 2022 Jan 6;23(1):21. doi: 10.1186/s13063-021-05956-5.
44 participants (actual enrollment reported by the registry).
First Submitted
February 20, 2020
First Posted
February 28, 2020
Contact the study team to confirm eligibility.
Study Start
December 18, 2020
Actual (reported)Primary Completion
September 27, 2024
Actual (reported)Study Completion
September 27, 2024
Actual (reported)Last Updated
October 15, 2024
Record last verified: 2024-10
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: